U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ASC-22
Preferred Name English
ENVAFOLIMAB
INN  
Official Name English
KN-035
Code English
ASC22
Code English
ANTI-PD-L1 MONOCLONAL ANTIBODY KN035
Common Name English
envafolimab [INN]
Common Name English
IMMUNOGLOBULIN G, ANTI-(HUMAN PROGRAMMED DEATH LIGAND 1) (HUMAN-CAMELIDAE MONOCLONAL KN-035 .GAMMA.-CHAIN VARIABLE REGION FRAGMENT) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN MONOCLONAL KN-035 .GAMMA.1-CHAIN FC FRAGMENT), DIMER
Common Name English
KN035
Code English
Envafolimab [WHO-DD]
Common Name English
IMMUNOGLOBULIN VH-H-CH2-CH3 GAMMA1 CHAIN DIMER, ANTI-(HOMO SAPIENS CD274 (PROGRAMMED DEATH LIGAND 1, PDL1, PD-L1, B7 HOMOLOG 1, B7H1)), MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN VH-H-CH2-CH3 (1-360) (VH (VICUGNA PACOS IGHV3-3*01 (80.6%)-(IGHD)-IGHJ5*01 (92.3
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C128057
Created by admin on Tue Apr 01 23:14:40 GMT 2025 , Edited by admin on Tue Apr 01 23:14:40 GMT 2025
FDA ORPHAN DRUG 745320
Created by admin on Tue Apr 01 23:14:40 GMT 2025 , Edited by admin on Tue Apr 01 23:14:40 GMT 2025
NCI_THESAURUS C129822
Created by admin on Tue Apr 01 23:14:40 GMT 2025 , Edited by admin on Tue Apr 01 23:14:40 GMT 2025
FDA ORPHAN DRUG 718819
Created by admin on Tue Apr 01 23:14:40 GMT 2025 , Edited by admin on Tue Apr 01 23:14:40 GMT 2025
Code System Code Type Description
FDA UNII
ES1M06M6QH
Created by admin on Tue Apr 01 23:14:40 GMT 2025 , Edited by admin on Tue Apr 01 23:14:40 GMT 2025
PRIMARY
CAS
2102192-68-5
Created by admin on Tue Apr 01 23:14:40 GMT 2025 , Edited by admin on Tue Apr 01 23:14:40 GMT 2025
PRIMARY
NCI_THESAURUS
C129714
Created by admin on Tue Apr 01 23:14:40 GMT 2025 , Edited by admin on Tue Apr 01 23:14:40 GMT 2025
PRIMARY
SMS_ID
300000005900
Created by admin on Tue Apr 01 23:14:40 GMT 2025 , Edited by admin on Tue Apr 01 23:14:40 GMT 2025
PRIMARY
INN
10930
Created by admin on Tue Apr 01 23:14:40 GMT 2025 , Edited by admin on Tue Apr 01 23:14:40 GMT 2025
PRIMARY
ACTIVE MOIETY
ENVAFOLIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966